科学图书馆
-
Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesSD Wiviott，I Raz，DECLARE–TIMI 58 Investigators. -
Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV TrialF Cosentino , CP Cannon , DZI Cherney et al.
-
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF RegistriesKi Hong Choi Jin‐Oh Choi et al.
-
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of AmericaDunlay SM, Givertz MM, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America.
-
The year in cardiology: heart failure: The year in cardiology 2019JGF Cleland, AR Lyon, T McDonagh et al.
-
Mechanical circulatory support devices for acute right ventricular failureKapur NK, Esposito ML, Bader Y et al.
-
Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failureCR Olsen, RJ Mentz, KJ Anstrom et al.
-
Association of Abnormal Left Ventricular Functional Reserve With Outcome in Heart Failure With Preserved Ejection FractionKosmala W, Przewlocka-Kosmala M, Marwick TH et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
